MedTrace Logo

Molecular Assessment of Drug Resistance Markers in Asymptomatic Malaria Cases and Malaria Antibody Kinetic

NCT02708199 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1179

Last updated 2016-03-15

No results posted yet for this study

Summary

Detection of the drug resistance molecular markers for falciparum and vivax in Longitudinal follow-up samples collected in Shwegyin Township, Bago Region that is Artemisinin Resistance Containment Tier I.

Conditions

  • Increased Drug Resistance
  • Asymptomatic Infection
  • Malaria

Sponsors & Collaborators

  • Kangwon National University

    collaborator OTHER

  • Department of Medical Research, Lower Myanmar

    lead OTHER

Eligibility

Min Age
6 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2015-12-31
Completion
2015-12-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02708199 on ClinicalTrials.gov